HomeInsightsResults

Fredun Pharmaceuticals Ltd Quarterly Result

Fredun Pharmaceuticals Ltd Quarterly Result

stocks purchased

₹ 0.6 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

8.6 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 24, 2024

Image

Fredun Pharmaceuticals Ltd

NSE: FREDUNPHARMA

Net Profit

₹ 4.27

Last updated on: Nov 24, 2024

Key Highlights

  • The revenue of Fredun Pharmaceuticals Ltd for the Sep '24 is ₹ 107.35 crore as compare to the Jun '24 revenue of ₹ 78.81 crore. This represent the growth of 36.21368%.
  • The ebitda of Fredun Pharmaceuticals Ltd for the Sep '24 is ₹ 13.95 crore as compare to the Jun '24 ebitda of ₹ 10.48 crore. This represent the growth of 33.11069%.
  • The net profit of Fredun Pharmaceuticals Ltd for the Sep '24 is ₹ 4.27 crore as compare to the Jun '24 net profit of ₹ 4.13 crore. This represent the growth of 3.3898273%.

Results Analysis

Market Price of Fredun Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Fredun Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024673.7
21 Nov 2024672
19 Nov 2024693.45
18 Nov 2024692.85
14 Nov 2024677.95
13 Nov 2024689.85
12 Nov 2024710.05
11 Nov 2024704.45
08 Nov 2024707.8
07 Nov 2024712.9

Historical Revenue of Fredun Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Fredun Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Fredun Pharmaceuticals Ltd

No data available

* All values are in crore

Fredun Pharmaceuticals Ltd News Hub

News

Fredun Pharmaceuticals to discuss results

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 26 ...

Read more

16 Oct 202411:59

News

Fredun Pharmaceuticals to hold board meeting

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 3 O...

Read more

27 Sep 202410:45

News

Fredun Pharmaceuticals to hold AGM

Fredun Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will...

Read more

19 Sep 202417:53

News

Fredun Pharmaceuticals AGM scheduled

Fredun Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will...

Read more

19 Sep 202410:08

News

Fredun Pharmaceuticals schedules board meeting

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 ...

Read more

22 Jul 202410:12

News

Board of Fredun Pharmaceuticals recommends final dividend

Fredun Pharmaceuticals announced that the Board of Directors of the Company at its meeting...

Read more

08 May 202409:31

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Fredun Pharmaceuticals Ltd Quarterly Result

What is the EPS of Fredun Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Fredun Pharmaceuticals Ltd is 37.64. An EPS is the amount of net income attributed to each share of a common stock.

How is Fredun Pharmaceuticals Ltd EPS calculated?

The EPS of Fredun Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Fredun Pharmaceuticals Ltd report its EPS?

Fredun Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Fredun Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Fredun Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Fredun Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Fredun Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*